theophylline has been researched along with tacrolimus in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 11 (64.71) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hossain, M; Okubo, Y; Sekiguchi, M | 1 |
| Guengerich, FP; Hata, T; Iwasaki, K; Matsuda, H; Shiraga, T; Tozuka, Z | 1 |
| Boubenider, S; Charpentier, B; Hiesse, C; Lambotte, O; Roy, S; Taburet, AM; Vincent, I | 1 |
| Akdis, CA; Akdis, M; Blaser, K; Bröcker, EB; Disch, R; Schmid-Grendelmeier, P; Trautmann, A | 1 |
| Kashimawo, LA; Kuluz, JW; McLaughlin, GE; Steele, BW | 1 |
| Abitbol, C; McLaughlin, GE; Perez, M; Ruiz, P; Schober, M; Steele, BW | 1 |
| Carcillo, JA; Thomas, NJ | 1 |
| Arai, I; Hashimoto, Y; Kurachi, M; Takano, N | 1 |
| Alva, MD; Egea, M; McLaughlin, GE | 1 |
| Barilli, A; Bonomini, S; Bussolati, O; Closs, EI; Dall'Asta, V; Gazzola, GC; Parolari, A; Sala, R; Simon, A; Tremoli, E; Visigalli, R | 1 |
1 review(s) available for theophylline and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for theophylline and tacrolimus
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of various drugs (staurosporine, herbimycin A, ketotifen, theophylline, FK506 and cyclosporin A) on eosinophil viability.
Topics: Alkaloids; Asthma; Benzoquinones; Cell Survival; Cyclosporine; Eosinophils; Humans; Ketotifen; Lactams, Macrocyclic; Protein Kinase C; Protein-Tyrosine Kinases; Quinones; Rifabutin; Staurosporine; Tacrolimus; Theophylline | 1994 |
Interactions of FK506 (tacrolimus) with clinically important drugs.
Topics: Drug Interactions; Humans; Immunosuppressive Agents; Microsomes, Liver; Prednisolone; Tacrolimus; Theophylline | 1996 |
Interaction between theophylline and tacrolimus in a renal transplant patient.
Topics: Adult; Drug Interactions; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Tacrolimus; Theophylline; Vasodilator Agents | 2000 |
Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
Topics: Acute Disease; Apoptosis; Cells, Cultured; Cyclosporine; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dexamethasone; fas Receptor; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukin-12; Keratinocytes; Sirolimus; T-Lymphocytes; Tacrolimus; Th1 Cells; Theophylline | 2001 |
Reversal of acute tacrolimus-induced renal vasoconstriction by theophylline in rats.
Topics: Analysis of Variance; Animals; Data Interpretation, Statistical; Glomerular Filtration Rate; Immunosuppressive Agents; Infusions, Intravenous; Kidney; Male; Phosphodiesterase Inhibitors; Placebos; Prospective Studies; Purinergic P1 Receptor Antagonists; Random Allocation; Rats; Rats, Sprague-Dawley; Renal Circulation; Tacrolimus; Theophylline; Time Factors; Vasoconstriction | 2003 |
Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats.
Topics: Adenosine; Animals; Creatinine; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Tacrolimus; Theophylline; Vasoconstriction; Vasodilator Agents | 2003 |
Theophylline for acute renal vasoconstriction associated with tacrolimus: a new indication for an old therapeutic agent?
Topics: Aminophylline; Animals; Calcineurin Inhibitors; Child; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Pediatric; Kidney; Organ Transplantation; Phosphodiesterase Inhibitors; Purinergic P1 Receptor Antagonists; Rats; Renal Circulation; Tacrolimus; Theophylline; Vasoconstriction | 2003 |
Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice.
Topics: Alprostadil; Animals; Antipruritics; Behavior, Animal; Capsaicin; Chlorpheniramine; Cyproheptadine; Dermatitis, Atopic; Dexamethasone; Dibucaine; Male; Mice; Mice, Inbred Strains; Naloxone; Pinacidil; Pruritus; Tacrolimus; Theophylline; Time Factors | 2004 |
Adenosine receptor antagonism in acute tacrolimus toxicity.
Topics: Animals; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Renal Circulation; Tacrolimus; Theophylline | 2006 |
In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blotting, Western; Cardiovascular Agents; Carrier Proteins; Caspase 3; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; E-Selectin; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Humans; Immunoprecipitation; L-Lactate Dehydrogenase; Mechanistic Target of Rapamycin Complex 1; Microscopy, Confocal; Multiprotein Complexes; Necrosis; Nitric Oxide; Nitric Oxide Synthase Type III; Polymerase Chain Reaction; Protein Kinases; Proteins; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Stress Fibers; Tacrolimus; Theophylline; Time Factors; TOR Serine-Threonine Kinases; Transcription Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |